HC stays probe against ‘producer’ of communally provocative fake news

News Network
April 11, 2018

Bengaluru, Apr 11: In a relief for Mahesh Vikram Hegde, the founder and editor of Postcardnews, the high court has ordered an interim stay on the Central Crime Branch (CCB) police investigation against him, in connection with creating a communally provocative fake news to disturb the peace.

On Tuesday, Justice Aravind Kumar heard the petition filed by Hegde and ordered the stay on the lower court proceedings in criminal case numbers 778/2018 till the further orders and also stayed the investigation.

Justice Kumar further ordered notices to the CCB cybercrime police and complainant Gafar Baig in the case.

The advocate representing the petitioner submitted that the Congress government in the state was filling unnecessary cases against Hegde and he had not published fake news.

The CCB cybercrime cell arrested Hegde in Bengaluru on March 29 for posting a fake news post. In the video, Hegde claimed that a Jain muni was attacked by a Muslim youth near Nanjangud and people were unsafe in the Siddaramaiah dispensation. The post was shared more than 6,000 times. In fact the Jain muni was an accident victim and not the victim of any assault.

While the police are also on the lookout for the portal's two news managers - Gaurav Pradhan and Deepak Shetty - who were also named in the complaint. There are four cases filed against Hegde over publishing fake news.

Comments

Ganesh
 - 
Wednesday, 11 Apr 2018

Who wants to protect him.. terrible

Danish
 - 
Wednesday, 11 Apr 2018

Instead of confining activists, artists, should do to these criminal

Huccha Venkat Army
 - 
Wednesday, 11 Apr 2018

No wonder.. Feku supports the fake news.. He got the name because of his fakeness

Kalimama
 - 
Wednesday, 11 Apr 2018

Kill this bastar*d...he will do any things to gain money even ready to sell his mother to prost racket...he is disgrace to humanity...only people who came from pigs womb will support him like B*P.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

Mangalore, Feb 4: Final chance to present evidence and record eyewitness statements with the Deputy Commissioner of Udupi G Jagadeesh regarding the December 19 violence will be held on February 6 between 1100 and 1300 hrs.

Eyewitness and evidence presenters can depose at the Assistant’s Commissioner’s Court Hall in the Mini Vidhan Soudha in the city.

The Deputy Commissioner said that no evidence would be accepted after this last round of public hearing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
May 20,2020

Udupi, May 20: All the six fishermen were rescued from a deep-sea fishing boat, which capsized after hitting a rock near Malpe here yesterday. 

The boat was owned by Reshma Kharvi. The incident occurred while the boat was returning after fishing to Malpe harbor. 

The helmsman lost control over the boat after steering got damaged and hit the rock and damaged. 

The crew of another boat which was near to the sinking boat immediately rushed and rescued six fishermen.

Attempts to rescue the sinking boat using the yet another boat could not materialise. 

The loss is said to be about Rs 80 lakh, including Rs. 5 lakh worth items, including fish, net, and other accessories. The boat ventured from Malpe port on May 14.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.